RESTORE-1
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial of Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation to Sinus Rhythm
- Stadium
- klaar
- Middel
- FlecIH-103
- Populatie
- Ritme
- Fase
- III
- First Patient In
- 15 augustus 2022
- Last Patient In
- 18 mei 2023
- Last Patient Last Visit
- 18 mei 2023
National Lead
prof. dr. M. Rienstra
Studiedirecteur
dr. S. Eijsbouts
Cardioloog
Contact Kantoor
